Evidence map›Paper›PMID 41488707›Full record

ArticleJournal of current ophthalmology

The Effect of Ocular Hypotensive Medications on Posterior Segment Blood Flow in Healthy Subjects: A Prospective, Randomized, and Interventional Study.

Saeed Shokouhi Rad, Marzieh Ghannad, Nasser Shoeibi, Elham Bakhtiari, Hamid Reza Heidarzadeh

Abstract read
In one paragraph

Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saeed Shokouhi RadEye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Marzieh GhannadEye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Nasser ShoeibiEye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Elham BakhtiariEye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Hamid Reza HeidarzadehEye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the immediate impact of topical ocular hypotensive medications on peripapillary and macular blood flow in healthy adults from Northeast Iran. Methods: A prospective, randomized, and interventional study was conducted on 80 healthy volunteers, with each volunteer having one eye treated with either brimonidine, dorzolamide, latanoprost, or timolol, all of which are ocular hypotensive medications. The study included a placebo treatment for one eye of each participant to serve as a control. At the peak effect of the drugs, all participants underwent an optical coherence tomography angiography scan of their eyes. A total of 160 eyes were included in the study. Results: According to the findings, the use of ocular hypotensive drugs did not demonstrate any significant influence on the radial peripapillary capillary network. However, the results indicated that a single dose of dorzolamide could result in a significant increase in macular blood flow ( Conclusions: According to our findings, dorzolamide was the most effective in enhancing young adults' full macular thickness and macular blood flow. Conversely, timolol treatment was found to decrease the macular blood flow, which in turn may cause visual field defects due to optic nerve head and macular ischemia in patients with low-tension glaucoma.

Indexed as

GlaucomaMaculaOcular hypotensive medicationOptical coherence tomography angiographyOptic nerve head

Identifiers

PMID41488707
PMCPMC12758861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.